세계의 DTC(Direct to Consumer) 검사 시장 규모는 2023년 16억 달러에서 예측 기간 중 CAGR 12.5%로 추이하며, 2029년에는 32억 달러에 달할 것으로 예측되고 있습니다.
유전자 DTC 검사 부문은 2023년 13억 달러에서 CAGR 12.7%로 추이하며, 2029년에는 27억 달러에 달할 것으로 예측되고 있습니다. 또한 마이크로바이옴 DTC 검사 부문은 2023년 513억 달러에서 CAGR 13.7%로 추이하며, 2029년에는 1,095억 달러에 달할 것으로 예측되고 있습니다.
세계의 DTC(Direct to Consumer) 검사 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 신규 기술 및 기술개발의 동향, 특허 동향, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
- 개요
- PESTEL 분석
- Porter's Five Forces 분석
- 업계에서 경쟁
- 규제 상황
- 미국
- 유럽
- 아시아태평양
- 기타 지역
제3장 시장 역학
- 시장 역학
- 시장 촉진요인
- 소비자와 의사 의식의 향상
- 유전자 배열 해석의 비용 하락
- 시장 억제요인
- 규제 가이드라인의 결여
- 결과의 부정확성
- 시장 기회
- 신흥 경제국
- 시장이 해결해야 할 과제
- 윤리와 데이터 프라이버시 문제
제4장 신규 기술과 개발
- 신기술
- 유전자 배열 해석의 진보
- 디지털화
- AI
- 특허 분석
- 특허 : 기업별
제5장 시장 세분화 분석
- 부문별 내역
- 시장 분석 : 검사 유형별
- 유전자 DTC 검사
- 바이오마커 기반 DTC 검사
- 마이크로바이옴 DTC 검사
- 시장 분석 : 용도별
- 건강·웰니스
- 조상·계보
- 질병 리스크 평가
- 캐리어 스크리닝
- 약리유전학적 검사
- 전게놈 배열에 기반한 DTC 검사
- 기타
- 시장 분석 : 유통 채널별
- 온라인
- 소매
- 지역적 내역
- 시장 분석 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제6장 경쟁 정보
제7장 DTC(Direct to Consumer) 검사에서의 지속가능성 : ESG 관점
- ESG : 개요
- DTC 검사 업계에서의 지속가능성 : ESG 관점
- 주요 ESG상 문제
- DTC 검사 업계의 ESG 퍼포먼스 분석
- BCC에 의한 결론
제8장 부록
- 조사 방법
- 전시
- 두자어
- 기업 개요
- 23ANDME INC.
- ANCESTRY
- GENETIC TECHNOLOGIES LTD.
- EVERLYWELL INC.
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- MAPMYGENOME
- MICROBIOME LABS
- MYHERITAGE LTD.
- QUEST DIAGNOSTICS INC.
- VIOME LIFE SCIENCES INC.
KSA
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
The genetic DTC tests market for DTC testing is estimated to increase from $1.3 billion in 2023 to reach $2.7 billion by 2029, at a CAGR of 12.7% from 2024 through 2029.
The microbiome DTC tests market for DTC testing is estimated to increase from $51.3 billion in 2023 to reach $109.5 billion by 2029, at a CAGR of 13.7% from 2024 through 2029.
Report Scope
The current report provides detailed information about the direct-to-consumer (DTC) testing market. The report provides market projections for 2029 and market share for key market players. It details the market size of DTC testing based on test types, applications and distribution channels. Based on the test type, the DTC testing market is segmented into genetic DTC tests, biomarker-based DTC tests and microbiome DTC tests. The report excludes at-home pregnancy tests, fertility tests and COVID-19 tests. Provider-dependent at-home tests also are not included in this report. The report is segmented into health and wellness testing, ancestry and genealogy testing, carrier screening, disease risk assessment, pharmacogenetic testing, whole genome sequence-based DTC testing and other DTC tests based on application. Based on the distribution channel, the market is categorized into online and retail.
Report Includes
- 21 data tables and 42 additional tables
- Analysis of the global market landscape of direct-to-consumer (DTC) testing industry
- Analyses of the global market trends, with market revenue data for 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
- Estimate of the current market size and revenue prospects, along with a market share analysis by test type, application, distribution channel and region
- Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, and the expected impact of macroeconomic factors
- An analysis of patents related to DTC
- Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
- An analysis of the industry structure, including companies' market shares, M&A activity, and venture funding
- Company profiles of major players within the industry, including Ancestry, 23andMe Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., and MyHeritage Ltd.
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- PESTEL Analysis
- Porter's 5 Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential of New Entrants
- Threat of Substitutes
- Competition in the Industry
- Regulatory Landscape
- U.S.
- Europe
- Asia-Pacific
- Rest of the World
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Rising Consumer and Physician Awareness
- Decreasing Costs of Genetic Sequencing
- Market Restraints
- Lack of Regulatory Guidelines
- Inaccuracy of Results
- Market Opportunities
- Emerging Economies
- Market Challenges
- Ethical and Data Privacy Issues
Chapter 4 Emerging Technologies and Developments
- Emerging Technologies
- Advances in Gene Sequencing
- Digitalization
- Artificial Intelligence
- Patent Analysis
- Patents, by Company
Chapter 5 Market Segmentation Analysis
- Segmental Breakdown
- Market Analysis, by Test Type
- Genetic DTC Tests
- Biomarker-based DTC Tests
- Microbiome DTC Tests
- Market Breakdown, by Application
- Health and Wellness Testing
- Ancestry and Genealogy Testing
- Disease Risk Assessment
- Carrier Screening
- Pharmacogenetic Testing
- Whole Genome Sequence-based DTC Testing
- Other DTC Tests
- Market Breakdown, by Distribution Channel
- Online Channel
- Retail Channels
- Geographic Breakdown
- Market Analysis, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Market Analysis
- Top Players
- Strategic Analysis
Chapter 7 Sustainability in Direct-to-Consumer Testing: ESG Perspective
- Introduction to ESG
- Sustainability in Direct-to-Consumer (DTC) Testing Industry: An ESG Perspective
- Key ESG Issues
- DTC Testing Industry ESG Performance Analysis
- Concluding Remarks from BCC
Chapter 8 Appendix
- Methodology
- Sources
- Acronyms
- Company Profiles
- 23ANDME INC.
- ANCESTRY
- GENETIC TECHNOLOGIES LTD.
- EVERLYWELL INC.
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- MAPMYGENOME
- MICROBIOME LABS
- MYHERITAGE LTD.
- QUEST DIAGNOSTICS INC.
- VIOME LIFE SCIENCES INC.
